moxifloxacin has been researched along with Glaucoma, Suspect in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
De-La-Torre, A; Gutiérrez, NM; Muñoz-Ortiz, J; Peñaranda-Henao, M; Reyes-Guanes, J | 1 |
Den Beste, KA; Okeke, C | 1 |
Banta, JT; Flynn, HW; Schimel, AM; Stringham, JD | 1 |
Bettis, DI; Morshedi, RG; Moshirfar, M; Vitale, AT | 1 |
1 review(s) available for moxifloxacin and Glaucoma, Suspect
Article | Year |
---|---|
Bilateral acute iris transillumination following systemic moxifloxacin for respiratory illness: report of two cases and review of the literature.
Topics: Adult; Aged; Anti-Infective Agents; Antihypertensive Agents; Aza Compounds; Female; Fluoroquinolones; Humans; Iris Diseases; Male; Moxifloxacin; Ocular Hypertension; Pigment Epithelium of Eye; Quinolines; Respiratory Tract Infections; Trabecular Meshwork; Transillumination; Treatment Outcome | 2012 |
3 other study(ies) available for moxifloxacin and Glaucoma, Suspect
Article | Year |
---|---|
Anterior Uveitis Due to Intracameral Moxifloxacin: A Case Report.
Topics: Anterior Chamber; Anti-Bacterial Agents; Cataract Extraction; Diagnosis, Differential; Drug-Related Side Effects and Adverse Reactions; Endophthalmitis; Exfoliation Syndrome; Eye Pain; Gonioscopy; Humans; Male; Middle Aged; Moxifloxacin; Ocular Hypertension; Photophobia; Uveitis, Anterior | 2021 |
Trabeculotomy ab interno with Trabectome as surgical management for systemic fluoroquinolone-induced pigmentary glaucoma: A case report.
Topics: Anti-Bacterial Agents; Cataract Extraction; Eye Pain; Female; Fluoroquinolones; Glaucoma, Open-Angle; Humans; Middle Aged; Moxifloxacin; Ocular Hypertension; Photophobia; Pneumonia, Bacterial; Trabeculectomy | 2017 |
Dropless Cataract Surgery: What Are the Potential Downsides?
Topics: Anti-Infective Agents, Local; Antibiotic Prophylaxis; Drug Compounding; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Glucocorticoids; Humans; Lens Implantation, Intraocular; Moxifloxacin; Ocular Hypertension; Ophthalmic Solutions; Phacoemulsification; Risk Factors; Triamcinolone; Vancomycin | 2016 |